In a rat model of PD, the 5-HT4R agonist prucalopride selectively enhanced L-DOPA-stimulated DA release in the rat SNr and the PFC but not in the hippocampus or the striatum [42]. This evidence concerns the gene HTR4 and Parkinson disease.